Scholarlink

<p>The ssrA-sspB dimerization system, derived from the bacterial degradation machinery, comprises a 7-residue ssrA peptide and its binding partner sspB. The compact size of ssrA makes it ideal for insertion into proteins of interest to manipulate host protein function by engineered light-responsive sspB. In contrast to the LOV2 caging strategy employed to develop optical dimerizers, we present herein two distinct photo-inducible binary interaction tools (PhoBITs) systems: PhoBIT1, a light-OFF switch generated by integrating LOV2 into sspB, and PhoBIT2, a light-ON switch building upon an evolved ssrA/CRY2-sspB pair with minimal basal interaction. These tools enable mechanistic dissection and optogenetic modulation of GPCRs, ion channels, necroptosis, and innate immune signaling. When incorporated into a monobody, PhoBIT2 allows photo-switchable inhibition of an oncogenic fusion protein to curtail leukemogenesis in vivo. Collectively, through targeted ssrA insertions, PhoBITs offer versatile control over diverse protein functions, thereby expanding possibilities for optogenetic engineering and potential therapeutic applications.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Engineering of photo-inducible binary interaction tools for biomedical applications

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年7月28日

查看全文
  • Yi-Tsang Lee,
  • Lei Guo,
  • Tien-Hung Lan,
  • Tatsuki Nonomura,
  • Gan Liu,
  • Guolin Ma,
  • Rui Wang,
  • Yun Huang,
  • Yubin Zhou

摘要

The ssrA-sspB dimerization system, derived from the bacterial degradation machinery, comprises a 7-residue ssrA peptide and its binding partner sspB. The compact size of ssrA makes it ideal for insertion into proteins of interest to manipulate host protein function by engineered light-responsive sspB. In contrast to the LOV2 caging strategy employed to develop optical dimerizers, we present herein two distinct photo-inducible binary interaction tools (PhoBITs) systems: PhoBIT1, a light-OFF switch generated by integrating LOV2 into sspB, and PhoBIT2, a light-ON switch building upon an evolved ssrA/CRY2-sspB pair with minimal basal interaction. These tools enable mechanistic dissection and optogenetic modulation of GPCRs, ion channels, necroptosis, and innate immune signaling. When incorporated into a monobody, PhoBIT2 allows photo-switchable inhibition of an oncogenic fusion protein to curtail leukemogenesis in vivo. Collectively, through targeted ssrA insertions, PhoBITs offer versatile control over diverse protein functions, thereby expanding possibilities for optogenetic engineering and potential therapeutic applications.